NantCell
Developing knowledge by harnessing the power of the immune system to treat cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
€109—164m (Dealroom.co estimates Dec 2018.)
Culver City California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $15.0m | Early VC | |
$75.0m | Growth Equity VC | ||
| N/A | $57.0m | Growth Equity VC | |
| N/A | $30.0m | Late VC | |
| Total Funding | €161m | ||
Recent News about NantCell
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by NantCell
Edit
ACQUISITION by NantCell Jun 2017
ACQUISITION by NantCell Jun 2015